fda warning letters compounded semaglutide tirzepatide september 2025 Issues Warnings Against Illegal GLP-1 Marketing FDA ramps up its pushback

For most trips, a cool bag in your hand luggage is enough

Richards is also the creator of The Candida Diet, a site that stresses the importance of a low-sugar, anti-inflammatory diet

Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with (MOUNJARO OR ZEPBOUND) [see Contraindications (4) and Warnings and Precautions (5.1)]. Trulicity has the following boxed warning (2025) (formerly known as a black box warning), related to dulaglutide the main ingredient in Trulicity, set forth below: WARNING: RISK OF THYROID C-CELL TUMORS In male and female rats, dulaglutide causes a dose-related and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure

Administration of placebo tablets concomitantly with oral semaglutide can reduce exposure to semaglutide by 35% in healthy subjects [28] and reinforces the dosing conditions to avoid administering other oral medications within 30 minutes of oral semaglutide [1, 28]

Makino et al., 2019

Contact your GP or diabetes specialist nurse if you experience sulphur burps accompanied by severe abdominal pain, persistent vomiting, or inability to keep food or fluids down for more than 24 hours